Natixis Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3M | Sell |
|
|||||
|
2025
Q1 | $73.7M | Buy |
|
|||||
|
2024
Q4 | $78.3M | Sell |
|
|||||
|
2024
Q3 | $123M | Buy |
|
|||||
|
2024
Q2 | $123M | Buy |
|
|||||
|
2024
Q1 | $110M | Buy |
|
|||||
|
2023
Q4 | $97M | Sell |
|
|||||
|
2023
Q3 | $91.4M | Sell |
|
|||||
|
2023
Q2 | $79.9M | Sell |
|
|||||
|
2023
Q1 | $92M | Buy |
|
|||||
|
2022
Q4 | $77.5M | Sell |
|
|||||
|
2022
Q3 | $92.9M | Sell |
|
|||||
|
2022
Q2 | $79.9M | Sell |
|
|||||
|
2022
Q1 | $123M | Sell |
|
|||||
|
2021
Q4 | $114M | Sell |
|
|||||
|
2021
Q3 | $153M | Buy |
|
|||||
|
2021
Q2 | $76.6M | Sell |
|
|||||
|
2021
Q1 | $65.5M | Sell |
|
|||||
|
2020
Q4 | $69.3M | Sell |
|
|||||
|
2020
Q3 | $104M | Sell |
|
|||||
|
2020
Q2 | $121M | Sell |
|
|||||
|
2020
Q1 | $102M | Buy |
|
|||||
|
2019
Q4 | $78.4M | Sell |
|
|||||
|
2019
Q3 | $58.4M | Buy |
|
|||||
|
2019
Q2 | $64.8M | Buy |
|
|||||
|
2019
Q1 | $84.8M | Buy |
|
|||||
|
2018
Q4 | $74.4M | Sell |
|
|||||
|
2018
Q3 | $83.3M | Buy |
|
|||||
|
2018
Q2 | $65.3M | Buy |
|
|||||
|
2018
Q1 | $61.6M | Buy |
|
|||||
|
2017
Q4 | $49.7M | Buy |
|
|||||
|
2017
Q3 | $57.2M | Sell |
|
|||||
|
2017
Q2 | $65.3M | Buy |
|
|||||
|
2017
Q1 | $50.1M | Buy |
|
|||||
|
2016
Q4 | $38.9M | Buy |
|
|||||
|
2016
Q3 | $28.3M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $1.97M | Buy |
|
|||||
|
2014
Q1 | $1.77M | Buy |
|
|||||
|
2013
Q4 | $287K | Buy |
|
|||||
|
2013
Q3 | $299K | Buy |
|